Get started
Author

Fernando Carvalho Neuenschwander

Observed names: F Neuenschwander, Fernando Carvalho neuenschwander, Fernando C. Neuenschwander, Fernando Neuenschwander
ORCID: 0000-0001-6387-7924
Observed ORCID: 0000-0001-6387-7924
OpenAlex ID: A5065213657
Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
2021 · Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, et al. · The Lancet · 482
PDF
The Changing Landscape for Stroke Prevention in AF
2017 · Menno V. Huisman, Kenneth J. Rothman, et al. · Journal of the American College of Cardiology · 280
PDF
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial
2021 · Zelalem Temesgen, Charles D Burger, et al. · The Lancet Respiratory Medicine · 68
PDF
Desfechos clínicos aos 30 dias do registro brasileiro das síndromes coronárias agudas (ACCEPT)
2013 · Luiz A lberto Piva e Mattos, Otávio Berwanger, et al. · Arquivos Brasileiros de Cardiologia · 50
PDF
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry
2023 · Giulio Francesco Romiti, Bernadette Corica, et al. · EClinicalMedicine · 46
PDF
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy
2020 · Kieran F. Docherty, Pardeep S. Jhund, et al. · Diabetes Care · 44
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
2022 · Gregory Y. H. Lip, Agnieszka Kotalczyk, et al. · Clinical Research in Cardiology · 33
PDF
Use of Evidence-Based Interventions in Acute Coronary Syndrome - Subanalysis of the ACCEPT Registry
2014 · Ricardo Wang, Fernando Carvalho Neuenschwander, et al. · Arquivos Brasileiros de Cardiologia · 29
Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial
2024 · Suzana Margareth Lobo, Gaétan Plantefève, et al. · EClinicalMedicine · 27
PDF
Extrapolating Long-term Event-Free and Overall Survival With Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction
2021 · Kieran F. Docherty, Pardeep S. Jhund, et al. · JAMA Cardiology · 18
PDF
Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia
2024 · Gerard T. Portela, Jeffrey L. Carson, et al. · Annals of Internal Medicine · 17
PDF
Avaliação do Seguimento de um Ano dos Pacientes Incluídos no Registro Brasileiro de Síndromes Coronárias Agudas (ACCEPT)
2020 · Pedro Gabriel Melo de Barros e Silva, Otavio Berwanger, et al. · Arquivos Brasileiros de Cardiologia · 16
PDF
Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction
2024 · François M. Carrier, Howard A. Cooper, et al. · JAMA Network Open · 8
PDF
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
2023 · Wern Yew Ding, Ameenathul Mazaya Fawzy, et al. · Journal of Thrombosis and Thrombolysis · 7
Implications for Clinical Practice from a Multicenter Survey of Heart Failure Management Centers
2021 · Edimar Alcides Bocchi, Henrique Turin Moreira, et al. · Clinics · 7
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Based upon FIO2 Requirements
2024 · Fernando Carvalho Neuenschwander, Ofra Barnett-Griness, et al. · Microorganisms · 6
PDF
Myocardial Infarction with ST Elevation and Reperfusion Therapy in Brazil: Data from the ACCEPT Registry
2024 · Luiz Eduardo Fonteles Ritt, Pedro Gabriel Melo de Barros e Silva, et al. · Arquivos Brasileiros de Cardiologia · 6
Aterosclerose e Inflamação: Ainda Muito Caminho a Percorrer
2020 · Ricardo Wang, Bruno Ramos Nascimento, et al. · Arquivos Brasileiros de Cardiologia · 4
PDF
Impact of cannabidiol on myocardial recovery in patients with acute myocarditis: primary results of the ARCHER study
2026 · Dennis M McNamara, Leslie T Cooper, et al. · ESC Heart Failure · 3
Infarto Agudo do Miocárdio com Supradesnível de ST e Terapia de Reperfusão no Brasil: Dados do Registro ACCEPT
2024 · Luiz Eduardo Fonteles Ritt, Pedro Gabriel Melo de Barros e Silva, et al. · Arquivos Brasileiros de Cardiologia · 3
PDF
Effect of Opaganib on Supplemental Oxygen and Mortality in Patients with Severe SARS-CoV-2 Pneumonia
2022 · Fernando Carvalho Neuenschwander, Ofra Barnett-Griness, et al. · medRxiv · 3
PDF
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
2020 · George Ntaios, Menno V. Huisman, et al. · Hellenic Journal of Cardiology · 3
PDF
Impact of the implementation of hospital work processes on reduced door-to-balloon time
2017 · Henrique Campos, Marcus Moreira, et al. · Journal of Transcatheter Interventions · 3
PDF
Há relação entre custos hospitalares e tempo porta‐balão?
2015 · Marcus Vinicius de Freitas Moreira, Luciana Alves Ribeiro, et al. · Revista Brasileira de Cardiologia Invasiva · 2
PDF
Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial
2024 · Pedro Gabriel Melo de Barros e Silva, Remo H. M. Furtado, et al. · Journal of Thrombosis and Thrombolysis · 1
Works count: 35
Citation count: 1,167
H-index: 12
I10-index: 12
Year
Topic
Type